sensorgram data using simultaneous fitting to the association and dissociation phases and global fitting to all curves in the set. A 1:1 Langmuir binding model closely fitted the observed sensorgram data and was used in all experiments.
Immunothrombocytopenia (ITP) model
ITP was induced by intravenous injection of 4 µg of 6A6 antibody variants as described (6, 15) . Platelet counts before and 4 hours after injection were determined by blood collection (40 µl) from the retro-orbital plexus and measuring platelet counts of a 1:10 dilution in PBS/5%BSA in an Advia 120 haematology system (Bayer).
Serum transfer, arthritis scoring and histology
Serum was prepared as described previously (19) . Arthritis was induced by one intravenous injection of 1.5x diluted K/BxN serum (4 µl of pooled K/BxN serum per gram of mouse). Arthritis was scored by clinical examination as described (19) . Index of all four paws was added: 0 [unaffected] , 1 [swelling of one joint], 2 [swelling of more than one joint], and 3 [severe swelling of the entire paw]. IVIG, fetuin (Sigma-Aldrich), or transferrin (Sigma-Aldrich) was injected 1 hr before K/BxN serum injection. For histological examination, ankle joints were fixed in 10% formalin, decalcified for 48 hr in Decal solution, and embedded in paraffin. Two micrometer sections were stained with hematoxylin/eosin.
Measurement of circulating human IgG levels in mice serum
Ninety-six-well ELISA plates coated with 5 µg/ml of F(ab') 2 goat anti-human IgG Fc antibody (Serotec) were incubated with diluted test sera (1/1000) after blocking with 5% bovine serum albumin. After washing with PBS containing 0.05% Tween 20, the plates were incubated with HRP-conjugated mouse anti-human IgG CH2 domain monoclonal antibody (Serotec). For the color development, 3,3',5,5'-tetramethylbenzidine was used.
Human IgG was used as a standard.
In vitro de-glycosylation and de-sialylation of IVIG and Fc
For in vitro de-glycosylation, 100 mg of IVIG in 1 ml of 0.2M sodium phosphate buffer (pH 8.5) was treated with 25,000 units of Peptide:N-Glycosidase F (PNGaseF) purified from Flavobacterium meningosepticum (New England BioLabs) at 37 o C for 40 h. For in vitro de-sialylation, 100 mg of IVIG or Fc fragment of IVIG in 1 ml of 0.05 M sodium citrate buffer (pH 6.0) was incubated with 700 units of recombinant α2,3/ α2,6
neuraminidase cloned from Clostridium perfringens (New England BioLabs) at 37 0 C for 20h. IVIG or Fc preparations were purified by Protein G affinity chromatography. The monomeric composition of the de-glycosylated and de-sialylated IVIG or Fc preparations was confirmed by SDS-PAGE.
Lectin affinity column purification
Agarose-bound SNA lectin (Vector Laboratories) was used for purification of human or mouse IgG containing sialic acid. Forty milligrams of IVIG or 10-15 mg of the 6A6-IgG1/IgG2b antibodies in 4 ml of Tris-buffered saline (TBS, pH 7.5) with 0.1 mM CaCl 2 were applied to 4ml of SNA column resin. Since the polyclonal IgG in IVIG may also contain N-linked glycans on the variable regions of the light and heavy chains that can be sialylated, we confirmed that the increase in anti-inflammatory activity of the SNAenriched IgG preparation resulted from increased sialylation of the N-linked glycosylation site on the Fc. For this Fc fragments were generated from unfractionated IVIG first by papain digestion. As for IVIG, 40mg of this purified Fc preparation were applied to 4ml of SNA column resin. After incubation at room temperature for 10 min, the SNA column was washed with 8 ml of TBS and the flow-through fraction was collected and defined as the non SNA-binding fraction. After additional washing with 8ml of TBS, IVIG, Fc fragment of IVIG, or 6A6 antibody isotypes bound to SNA were eluted in 4 ml of 0.5 M lactose in TBS for 10 min, followed by the same amount of 0.5 M lactose in 0.2 M acetic acid for another 10 min. The eluted IVIG fraction was purified in the same way a second time to increase enrichment. After buffer exchange into PBS by using a PD-10 desalting column (GE Healthcare) this preparation was used as the SNAenriched fraction.
Measurement of subclass distribution of IVIG
Subclass distribution of untreated IVIG or SNA-enriched IVIG was determined by ELISA. Ninety-six-well ELISA plates coated with 10 µg/ml of subclass-specific mouse anti-human IgG1 (clone HP6001), IgG2 (clone HP6014), IgG3 (clone HP6050) or IgG4
(clone HP6023) antibody were incubated with diluted IVIG after blocking with 5% bovine serum albumin. After washing with PBS containing 0.05% Tween 20, the plates were incubated with an HRP-conjugated mouse anti-human IgG CH2 domain monoclonal antibody (Serotec). For the color development, 3,3',5,5'-tetramethylbenzidine was used.
MALDI-TOF-MS analysis
Monosaccharide composition analysis was performed by UCSD GRTC Glycotechnology
Core Resource (San Diego, CA). Glycoprotein samples were denatured with SDS and 2-mercaptoethanol, and digested with PNGase F. The released mixed N-glycans were purified by reversed-phase HPLC and solid-phase extraction, and then all exposed hydroxyl groups of the N-glycans were permethylated to protect from the loss of sialic acid (S3 and Fig. S10 ). The resulting derivatized saccharides were purified again by reversed-phase HPLC and subjected to MALDI-TOF-MS. Glycan standards were purchased from QA-Bio (Palm Desert, CA). Note that this method does not allow to determine the precise arm structure and linkage of the sugar residues.
Lectin blot
The indicated amounts of 6A6 antibody variants, IVIG, or purified serum IgG or IgM from untreated or NTS treated mice were resolved by SDS-PAGE using polyacrylamide gel under reduced of non-reduced conditions. Proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (Milipore), blocked with Western Blocking Reagent (Roche), followed by incubation with biotinylated SNA lectin (2 µg/ml, Vector Laboratories) and alkaline phosphatase (AP-conjugated goat anti-biotin antibody (Sigma). Bound antibody was visualized with 4-nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (Roche). The relative intensity of bands was quantified using the NIH Image software. Specificity of SNA lectin blotting was verified by hapten inhibition with 0.5M N-acetylneuraminic acid (Fig. S11 ).
Immunoprecipitation
Mouse serum (1ml) was preincubated with 50 µl protein G sepharose (GE Healthcare) for 2 hours at 4 0 C. After removal of the protein G sepharose, 1 µg of anti-transferrin antibody (Bethyl laboratories) was added to the serum and incubated for 4 hours with shaking, followed by the addition of fresh protein G beads. After 2 hours the beads containing immunoprecipitated transferrin were recovered by centrifugation and washed two times with PBS before SDS PAGE gel analysis.
Platelet Elisa with 6A6 antibody isotypes and glycosylation variants
Platelets were isolated from peripheral blood by several consecutive centrifugation steps.
To collect plasma, cells were pelleted by centrifugation at 300xg for 5 minutes, followed by three washing steps with PBS (spin down platelets at 1500xg for 15 minutes). Finally, red blood cells were removed by centrifugation at 100xg for 10 minutes and the platelet containing supernatant was directly used for coating 96 well Elisa plates (Nunc Maxisorb). Platelets were coated overnight at 4 0 C in PBS. The next day platelets were fixed by addition of 2% paraformaldehyde (PFA) for 5 minutes. After washing three times with PBS, wells were blocked with PBS/1%BSA for 2 hours at room temperature, followed by incubation with the platelet specific 6A6 antibodies in PBS/1%BSA at the indicated concentrations for one hour at room temperature. After three more washes bound antibodies were detected by addition of a horseradish-peroxidase (HRP) coupled mouse IgG specific antibody (Bethyl laboratories) and addition of HRP substrate solution (KPL laboratories). When using SNA-rich antibody preparations we additionally included a control to evaluate the effect of sialic acid on secondary antibody (anti-mouse HRP conjugate) binding to sialic acid enriched antibody variants. For this, 6A6
antibodies or 6A6 SNA rich variants were coated directly to Elisa wells followed by detection with the secondary antibody. The difference that was obtained in this assay was used to correct the values obtained in the platelet Elisa.
Flow cytometry
Spleen and bone marrow cells were prepared and resuspended in PBS. After red blood cell lysis, cells were stained with the indicated monoclonal antibodies, and subjected to flow cytometric analysis.
Anti-GBM glomerulonephritis
Anti-GBM glomerulonephritis was induced as described previously (20). Briefly, mice were pre-immunized intraperitoneally with 200 µg of sheep IgG (Serotec) in CFA, followed by intravenous injection of 2.5 µl of NTS serum (S4) per gram body weight four days later. Blood was collected from non-treated control mice or anti-GBM nephritis mice 4 days after the anti-GBM antiserum injection, and serum IgG was purified by Protein G (GE Healthcare) and sepharose-bound sheep IgG column, generated by covalently coupling sheep IgG on NHS-activated sepharose column (GE Healthcare), affinity chromatography.
Lectin immunohistochemistry and immunofluorescence
Four micrometer frozen sections were fixed in acetone and incubated with 10 µg/ml of biotinylated SNA lectin after blocking with Western Blocking Reagent (Roche) and biotin blocking (DakoCytomation, Carpinteria, CA). After blocking of endogenous peroxidase, HRP-conjugated rabbit anti-biotin antibody (DakoCytomation) was used as a secondary antibody and 3-3'-diaminobenzidine for visualization. Immunofluorescence experiments were performed as previously described (20) 
Statistical analysis
Statistical differences of clinical scores were calculated with Mann-Whitney's U test.
Repeated measure ANOVA-test was used for difference of human IgG levels in mouse serum. Statistical differences of the ratio of F4/80+ Ly 17.2 + cells and between experimental groups in the ITP model were determined with Student's t test. P < 0.05 was considered significant.
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